Prenatal DHA supplementation and infant attention.
Pediatr Res
; 80(5): 656-662, 2016 11.
Article
em En
| MEDLINE
| ID: mdl-27362506
ABSTRACT
BACKGROUND:
Results of randomized trials on the effects of prenatal docosahexaenoic acid (DHA) on infant cognition are mixed, but most trials have used global standardized outcomes, which may not be sensitive to effects of DHA on specific cognitive domains.METHODS:
Women were randomized to 600 mg/d DHA or a placebo for the last two trimesters of pregnancy. Infants of these mothers were then followed on tests of visual habituation at 4, 6, and 9 mo of age.RESULTS:
DHA supplementation did not affect look duration or habituation parameters but infants of supplemented mothers maintained high levels of sustained attention (SA) across the first year; SA declined for the placebo group. The supplemented group also showed significantly reduced attrition on habituation tasks, especially at 6 and 9 mo.CONCLUSION:
The findings support with the suggestion that prenatal DHA may positively affect infants' attention and regulation of state.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Atenção
/
Ácidos Docosa-Hexaenoicos
/
Cognição
/
Suplementos Nutricionais
/
Fenômenos Fisiológicos da Nutrição Materna
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Pediatr Res
Ano de publicação:
2016
Tipo de documento:
Article